Hybio Pharmaceutical (300199) — Cash Flow-to-Debt Ratio
Hybio Pharmaceutical (300199) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥117.78 Million could theoretically repay 0% of its total liabilities (CN¥2.50 Billion) in one year. See cash generation quality of Hybio Pharmaceutical to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hybio Pharmaceutical Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for Hybio Pharmaceutical across 18 annual periods. Also explore 300199 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Hybio Pharmaceutical (2007–2024)
Year-by-year debt coverage analysis for Hybio Pharmaceutical. For market capitalisation and broader financial context, see 300199 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | CN¥164.71 Million | CN¥2.41 Billion | ▲ +4917.1% |
| 2023 | 0.00x | CN¥-3.54 Million | CN¥2.49 Billion | ▼ -120.8% |
| 2022 | 0.01x | CN¥15.81 Million | CN¥2.31 Billion | ▼ -90.2% |
| 2021 | 0.07x | CN¥156.83 Million | CN¥2.26 Billion | ▲ +238.9% |
| 2020 | 0.02x | CN¥47.99 Million | CN¥2.34 Billion | ▼ -51.2% |
| 2019 | 0.04x | CN¥104.64 Million | CN¥2.49 Billion | ▲ +102.7% |
| 2018 | 0.02x | CN¥47.00 Million | CN¥2.27 Billion | ▼ -86.3% |
| 2017 | 0.15x | CN¥213.74 Million | CN¥1.41 Billion | ▼ -56.5% |
| 2016 | 0.35x | CN¥296.41 Million | CN¥852.42 Million | ▲ +127.6% |
| 2015 | 0.15x | CN¥138.84 Million | CN¥908.68 Million | ▼ -60.0% |
| 2014 | 0.38x | CN¥153.43 Million | CN¥401.32 Million | ▼ -59.0% |
| 2013 | 0.93x | CN¥153.48 Million | CN¥164.48 Million | ▲ +15.0% |
| 2012 | 0.81x | CN¥87.19 Million | CN¥107.42 Million | ▼ -33.3% |
| 2011 | 1.22x | CN¥72.48 Million | CN¥59.56 Million | ▼ -28.1% |
| 2010 | 1.69x | CN¥54.69 Million | CN¥32.30 Million | ▲ +255.0% |
| 2009 | 0.48x | CN¥26.11 Million | CN¥54.73 Million | ▼ -61.1% |
| 2008 | 1.23x | CN¥45.75 Million | CN¥37.32 Million | ▼ -76.2% |
| 2007 | 5.14x | CN¥49.04 Million | CN¥9.54 Million | — |